ChartRow logo
Share this page
IBRX
$9.18-8.20%
as of close, Oct 16, 2026
☾ AH $9.18 -8.20%
PeersMRNALLYMDTUNHJNJTMO

IBRX — ImmunityBio Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in IBRX be worth today? →
IBRX returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$9.18
YTD price return
+363.64%
YTD total return
+363.64%
Next earnings
Nov 3, 2026
Market cap
9.7B
Enterprise value
9.4B
Shares outstanding
1.1B
52W low
$1.95
52W high
$12.43
From 52W high
-26.15%
From 52W low
+370.77%
52W range
69%

Volume

Rel volume
1.50×
30D volume
14.3M
30D $ vol
132M

Insider trading

Insider net 1W
none
Insider net 1M
−$1.1M
Insider net 3M
−$1.1M
Insider net 1Y
−$9.5M

Form 4 transactions by trade date, as filed; latest on file 2026-10-05.

Fundamentals

Sales (ttm)
165.8M
Sales/share
$0.16
EPS (ttm)
-$0.99
FCF (ttm)
-288.1M
FCF/share
-$0.27
Book value/share
-$0.99
Net margin
-598.56%
ROA
-157.89%
Current ratio
5.72

Growth (CAGR, ttm) · 10Y

Sales
+193.13%+553.98%+202.97%+128.38%
Shares
+12.13%+32.43%+22.06%+29.12%

Per-share growth (CAGR, ttm) · 10Y

Sales/share
+161.42%+393.83%+148.20%+76.87%
Price
+263.17%+87.59%-0.26%+3.34%
Total return
+263.17%+87.59%-0.26%+3.34%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
-9.3×
Fwd P/E
-70.0×
P/S (ttm)
58.7×
P/B (mrq)
-9.3×
EV/Sales (ttm)
56.8×
FCF yield (ttm)
-2.96%
Buyback yield (realized, 1y)
-12.13%
Shareholder yield (realized, 1y)
-12.13%
Buyback yield (cash, ttm)
0.00%
Shareholder yield (cash, ttm)
0.00%

Vs own 10Y history

P/S
11th
P/B
99th

Bar = where today’s multiple sits in IBRX’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

1D
-8.20%
5D
-12.65%
1M
+16.06%
3M
+23.22%
YTD
+363.64%
1Y
+262.85%
5Y
-1.29%

Recent filings#

All filings and insider trades →

Financial statements

Open full IBRX financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company+10.48%+0.43%
JNJJohnson & Johnson-4.38%+0.90%
ABBVAbbVie Inc.+8.73%+0.71%
UNHUnitedHealth Group Incorporated Common Stock (DE)+6.97%-1.29%
MRKMerck & Co. Inc.+0.72%+0.52%
NVSNovartis AG+8.59%+0.16%
TMOThermo Fisher Scientific Inc.+6.41%-0.93%
AMGNAmgen Inc.+14.92%-0.35%